Related references
Note: Only part of the references are listed.Dosing regimens, FVIII levels and estimated haemostatic protection with special focus on rFVIIIFc
E. Berntorp et al.
HAEMOPHILIA (2016)
Adherence to prophylactic treatment in patients with haemophilia in Germany
W. Miesbach et al.
HAEMOPHILIA (2016)
Understanding patient preferences and willingness to pay for hemophilia therapies
Shraddha S. Chaugule et al.
Patient Preference and Adherence (2015)
Developing a two-sided intervention to facilitate shared decision-making in haemophilia: decision boxes for clinicians and patient decision aids for patients
A. Athale et al.
HAEMOPHILIA (2014)
Changing paradigm of prophylaxis with longer acting factor concentrates
M. Carcao
HAEMOPHILIA (2014)
Development of long-acting recombinant FVIII and FIX Fc fusion proteins for the management of hemophilia
Amy Shapiro
EXPERT OPINION ON BIOLOGICAL THERAPY (2013)
What should men living with severe haemophilia need to know? The perspectives of Canadian haemophilia health care providers
S. Lane et al.
HAEMOPHILIA (2013)
Treatment patterns, health-related quality of life and adherence to prophylaxis among haemophilia A patients in the United States
N. Duncan et al.
HAEMOPHILIA (2012)
Haemophilia Care in Europe: the ESCHQoL study
W. Schramm et al.
HAEMOPHILIA (2012)
Physical activity and joint function in adults with severe haemophilia on long-term prophylaxis
Mohamed Khawaji et al.
BLOOD COAGULATION & FIBRINOLYSIS (2011)
A randomized clinical trial of prophylaxis in children with hemophilia A (the ESPRIT Study)
A. Gringeri et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2011)
Improvements in factor concentrates
David Lillicrap
CURRENT OPINION IN HEMATOLOGY (2010)
Joint outcomes in patients with haemophilia: the importance of adherence to preventive regimens
E. Berntorp
HAEMOPHILIA (2009)
Should prophylaxis be used in adolescent and adult patients with severe haemophilia? An European survey of practice and outcome data
M. Richards et al.
HAEMOPHILIA (2007)
Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia
Marilyn J. Manco-Johnson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Quality-of-life differences between prophylactic and on-demand factor replacement therapy in European haemophilia patients
S Royal et al.
HAEMOPHILIA (2002)
Barriers to compliance with prophylaxis therapy in haemophilia
MR Hacker et al.
HAEMOPHILIA (2001)
Share Paper
